Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis

This study has been completed.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by (Responsible Party):
Dennis Black, University of California, San Francisco Identifier:
First received: March 24, 2000
Last updated: February 4, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)